|
2
|
50
|
2rnlA |
Solution structure of the egf-like domain from human amphiregulin |
|
18
|
90
|
2rkyA |
Crystal structure of the fourth and fifth fibronectin f1 modules in complex with a fragment of staphylococcus aureus fnbpa-1 |
|
13
|
50
|
2tgfA |
The solution structure of human transforming growth factor alpha |
|
5
|
53
|
2ro4A |
Rdc-refined solution structure of the n-terminal dna recognition domain of the bacillus subtilis transition-state regulator abrb |
|
14
|
89
|
2rl0A |
Crystal structure of the fourth and fifth fibronectin f1 modules in complex with a fragment of staphylococcus aureus fnbpa-5 |
|
12
|
51
|
2ra0L |
X-ray structure of fxa in complex with 7-fluoroindazole |
|
22
|
127
|
2uwiA |
Structure of crme, a poxvirus tnf receptor |
|
13
|
105
|
2r52A |
Crystal structure analysis of bone morphogenetic protein-6 (bmp-6) |
|
12
|
107
|
2r53A |
Crystal structure analysis of bone morphogenetic protein-6 variant b2 (b2-bmp-6) |
|
4
|
57
|
2r33A |
Crystal structure of a bowman-birk inhibitor from vigna unguiculata seeds |
|
27
|
157
|
2qy0A |
Active dimeric structure of the catalytic domain of c1r reveals enzyme-product like contacts |
|
117
|
380
|
2qr6A |
Crystal structure of imp dehydrogenase/gmp reductase-like protein (np_599840.1) from corynebacterium glutamicum atcc 13032 kitasato at 1.50 a resolution |
|
34
|
317
|
2qj6A |
Crystal structure analysis of a 14 repeat c-terminal fragment of toxin tcda in clostridium difficile |
|
15
|
85
|
2qjbC |
Crystal structure analysis of bmp-2 in complex with bmpr-ia variant ia/ib |
|
15
|
104
|
2qj9A |
Crystal structure analysis of bmp-2 in complex with bmpr-ia variant b1 |
|
14
|
104
|
2qcwA |
Crystal structure of bone morphogenetic protein-6 (bmp-6) |
|
10
|
131
|
2qn5B |
Crystal structure and functional study of the bowman-birk inhibitor from rice bran in complex with bovine trypsin |
|
15
|
103
|
2qjbA |
Crystal structure analysis of bmp-2 in complex with bmpr-ia variant ia/ib |
|
10
|
74
|
2qc1A |
Crystal structure of the extracellular domain of the nicotinic acetylcholine receptor 1 subunit bound to alpha-bungarotoxin at 1.9 a resolution |
|
14
|
104
|
2qjaA |
Crystal structure analysis of bmp-2 in complex with bmpr-ia variant b12 |
|
17
|
107
|
2qcqA |
Crystal structure of bone morphogenetic protein-3 (bmp-3) |
|
12
|
51
|
2q1jB |
The discovery of glycine and related amino acid-based factor xa inhibitors |
|
13
|
95
|
2qr0C |
Structure of vegf complexed to a fab containing tyr and ser in the cdrs |
|
15
|
86
|
2qj9C |
Crystal structure analysis of bmp-2 in complex with bmpr-ia variant b1 |
|
13
|
85
|
2qjaC |
Crystal structure analysis of bmp-2 in complex with bmpr-ia variant b12 |
|
9
|
51
|
2p3fL |
Crystal structure of the factor xa/nap5 complex |
|
177
|
553
|
2oyuP |
Indomethacin-(s)-alpha-ethyl-ethanolamide bound to cyclooxygenase-1 |
|
12
|
79
|
2pjyC |
Structural basis for cooperative assembly of the tgf-beta signaling complex |
|
13
|
52
|
2p95L |
Factor xa in complex with the inhibitor 5-chloro-n-((1r,2s)-2-(4-(2-oxopyridin-1(2h)-yl)benzamido) cyclopentyl)thiophene-2-carboxamide |
|
18
|
116
|
2p6aA |
The structure of the activin:follistatin 315 complex |
|
17
|
94
|
2puqL |
Crystal structure of active site inhibited coagulation factor viia in complex with soluble tissue factor |
|
10
|
51
|
2phbB |
An orally efficacious factor xa inhibitor |
|
69
|
280
|
2p26A |
Structure of the phe2 and phe3 fragments of the integrin beta2 subunit |
|
20
|
112
|
2pjyA |
Structural basis for cooperative assembly of the tgf-beta signaling complex |
|
11
|
50
|
2pr3B |
Factor xa inhibitor |
|
13
|
52
|
2p93L |
Factor xa in complex with the inhibitor 5-chloro-n-(2-(4-(2-oxopyridin-1(2h)-yl)benzamido)ethyl)thiophene-2-carboxamide |
|
20
|
108
|
2pjyB |
Structural basis for cooperative assembly of the tgf-beta signaling complex |
|
12
|
52
|
2p3tA |
Crystal structure of human factor xa complexed with 3-chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide |
|
13
|
52
|
2p16L |
Factor xa in complex with the inhibitor apixaban (bms-562247) aka 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3, 4-c]pyridine-3-carboxamide |
|
12
|
51
|
2p3uA |
Crystal structure of human factor xa complexed with 3-chloro-n-(4-chloro-2-{[(5-chloropyridin-2-yl)amino]carbonyl}-6-methoxyphenyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]thiophene-2-carboxamide {pfizer 320663} |
|
13
|
52
|
2p94L |
Factor xa in complex with the inhibitor 3-chloro-n-((1r,2s)-2-(4-(2-oxopyridin-1(2h)-yl)benzamido)cyclohexyl)-1h-indole-6-carboxamide |
|
12
|
74
|
2p3fN |
Crystal structure of the factor xa/nap5 complex |
|
34
|
217
|
2p28B |
Structure of the phe2 and phe3 fragments of the integrin beta2 subunit |
|
10
|
58
|
2o13A |
Solution structure of the c-terminal lim domain of mlp/crp3 |
|
20
|
126
|
2o39C |
Human adenovirus type 11 knob in complex with domains scr1 and scr2 of cd46 (membrane cofactor protein, mcp) |
|
19
|
75
|
2ofsA |
Crystal structure of human cd59 |
|
8
|
63
|
2lojA |
Solution nmr structure of tstm1273 from salmonella typhimurium lt2, nesg target stt322, csgid target idp01027 and ocsp target tstm1273 |
|
7
|
82
|
2mupA |
Structure of the cis-(tyr39-pro40) form of the human secreted ly-6/upar related protein-1 (slurp-1) |
|
12
|
72
|
2lzuA |
Solution structure of limd2 |
|
9
|
96
|
2l6zC |
Haddock model of gata1nf:lmo2lim2-ldb1lid with fog |
